Answers are grounded in this paper and cite their sources.
Plasma concentration of 2-methoxyestradiol (2-ME) and placental expression of catechol-O-methyltransferase(COMT) are elevated in normal pregnancy, but reduced in women with preeclampsia (PE).Women with PE and fetal growth restriction (FGR)exhibit decreased utero-placental blood flow.Catechol-O-methyltransferase knockout mice (COMT -/-) and female CBA/J mice mated with male DBA/2 mice (CBA/J × DBA/2)show many signs of PE during pregnancy and deliver growth-restricted pups.2-ME is known to induce significant vasorelaxation of uterine arteries from pregnant mice.We hypothesized that 2-ME administration during pregnancy will lead to an increase in uterine artery blood flow velocity in COMT -/-and CBA/J × DBA/2 mice and therefore ameliorate PE-like signs and rescue fetal growth in these animal models.Pregnant COMT -/-and their controls (C57BL/6),and CBA/J × DBA/2 and their controls (CBA/J × BALB/c),were injected subcutaneously daily with 10 ng of 2-ME or vehicle (olive oil) from gestational day (GD) 12.5 to 17.5.There was no significant effect of genotype/strain or treatment on maternal blood pressure, uterine artery blood flow velocity or fetal growth.A perturbed phenotype only occurred in the COMT -/-mice in regard to umbilical artery flow velocity, proteinuria and 2-ME levels.Administration of 2-ME led to normalization ofumbilical artery blood flow velocity and proteinuria in COMT -/-mice.The utility of 2-ME in cases of PE and FGR needs to be further explored in PE models that exhibit more severe disease phenotypes.
No takes yet. Share an insight, caveat, or question.
Poudel et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: